Glimisave MV 3.3 Tablet SR
Marketer
Eris Lifesciences Ltd
Salt Composition
Glimepiride (3mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Glimisave MV 3.3 Tablet SR
Diabetic patients using Glimisave MV 3.3 SR tablets, an anti-diabetic medication, should understand its role in managing type 2 diabetes. This combined formulation aids in blood glucose regulation for adult patients. Administer this medication with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical guidance risks elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, it's a component of a broader diabetes management plan, encompassing diet, exercise, and weight control as directed by your doctor. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, dizziness, headache, and trembling, and know how to counteract them. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be limited due to its hypoglycemic risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling, blurry vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your doctor before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose checks are mandatory, and your doctor might recommend blood tests to monitor blood cell counts and liver function.
Primary Ingredients of Glimisave MV 3.3 Tablet SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Glimisave MV 3.3 Tablet SR
Managing type 2 diabetes
Major Benefits of Glimisave MV 3.3 Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimisave MV 3.3 Tablet SR on an empty stomach.
Common Side effects of Glimisave MV 3.3 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimisave MV 3.3 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimisave MV 3.3 Tablet SR whole; do not chew, crush, or divide it. Administer this extended-release tablet on an empty stomach.
How Glimisave MV 3.3 Tablet SR works:
Glimisave MV 3.3 SR tablets contain a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimisave MV 3.3 Tablet SR and alcohol poses a significant safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Glimisave MV 3.3 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimisave MV 3.3 Tablet may pose a risk to breastfeeding infants. Available evidence from human studies indicates potential transfer to breast milk and consequent harm to the nursing child.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney impairment should likely avoid Glimisave MV 3.3 Tablet SR, as its use may be unsafe. For those with severe kidney disease, its use is contraindicated. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Glimisave MV 3.3 Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. A low initial dose is typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Glimisave MV 3.3 Tablet SR :
Should you forget to take a Glimisave MV 3.3 Tablet SR, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimisave MV 3.3 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Medication |
3,018 People bought this recently